Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Buy back?

A question for you high-power investors who know such things.

PTSC has a known cash balance and reasonably predictable expenses (directors fees, PDSG salaries, rent, utlities, external accountants, external legal etc etc).

Absent any income, let's say there's enough for another 4 years, give or take. Insert your own guesstimate - but don't challenge mine as it's just "a number".

At today's prices PTSC could buy back stock at the rate of about $50,000 for a million shares, or $1M for 20,000,000 shares.

If the BOD believes there's future in MMP, wouldn't now be a good time to buy back and reduce the shares outstanding?

Experts: why wouldn't they do it?

Share
New Message
Please login to post a reply